Literature DB >> 10668949

Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level.

A E Grzegorzewska1, I Mariak, A Dobrowolska-Zachwieja.   

Abstract

OBJECTIVE: An evaluation of serum free carnitine level in CAPD patients in relation to dietary intake, nutritional status and CAPD adequacy and duration. STUDY
DESIGN: Food diaries, nutritional (total body mass, lean body mass, serum level of proteins, carnitine, cholesterol) and adequacy (Kt/V, PCR, tCcr, EN) parameters were obtained in 23 CAPD patients.
RESULTS: Normal carnitine level (41.8+/-6.7 micromol/l) was found in 17 patients being on CAPD through 11.1+/-9.6 months, whereas in 6 persons treated with CAPD through 9.7+/-4.1 months carnitine level was 25.4+/-5.7 micromol/l. Significant differences between low and normal carnitine groups were in tCcr (82.7+/-16.7 v. 65.9+/-13.2 l/wk/1.73 m2 BSA), effluent volume (10.9+/-0.8 v. 9.9+/-1.5 l/day), effluent glucose concentration (729+/-167 v. 530+/-220 mg/dl) and serum globulin level (22.6+/-6.4 v. 29.3+/-4.4 g/l). Significant correlation coefficients (for n = 23) were found between serum carnitine level and effluent volume (r=-0.509) or plasma globulin level (r=+0.522).
CONCLUSION: Patients with higher CAPD adequacy show lower serum free carnitine levels and this is related to higher effluent volumes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668949     DOI: 10.1023/a:1007127614765

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

1.  Nutrition of uremic patients in the course of CAPD treatment.

Authors:  A E Grzegorzewska; A Chmurak; A Dobrowolska-Zachwieja
Journal:  Adv Perit Dial       Date:  1996

2.  Increased serum carnitine concentration in renal insufficiency.

Authors:  S H Chen; S D Lincoln
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

3.  A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure.

Authors:  A V Moorthy; M Rosenblum; R Rajaram; A L Shug
Journal:  Am J Nephrol       Date:  1983 Jul-Aug       Impact factor: 3.754

4.  Total body water volumes for adult males and females estimated from simple anthropometric measurements.

Authors:  P E Watson; I D Watson; R D Batt
Journal:  Am J Clin Nutr       Date:  1980-01       Impact factor: 7.045

5.  Plasma carnitine levels in adult males in India: effects of high cereal, low fat diet, fat supplementation, and nutrition status.

Authors:  L Khan-Siddiqui; M S Bamji
Journal:  Am J Clin Nutr       Date:  1980-06       Impact factor: 7.045

6.  Carnitine metabolism in normal-weight and obese human subjects during fasting.

Authors:  C L Hoppel; S M Genuth
Journal:  Am J Physiol       Date:  1980-05

7.  Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples.

Authors:  V Savica; G Bellinghieri; C Di Stefano; E Corvaja; F Consolo; M Corsi; F Maccari; L G Spagnoli; S Villaschi; G Palmieri
Journal:  Nephron       Date:  1983       Impact factor: 2.847

8.  Evaluation of carnitine levels according to the peritoneal equilibration test in patients on continuous ambulatory peritoneal dialysis.

Authors:  C Chatzidimitriou; T Pliakogiannis; A Evangeliou; T Tsalkidou; H J Böhles; K Kalaitzidis
Journal:  Perit Dial Int       Date:  1993       Impact factor: 1.756

9.  Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis.

Authors:  T Pliakogiannis; C Chatzidimitriou; A Evangeliou; H J Böhles; K Kalaitzidis
Journal:  Perit Dial Int       Date:  1993       Impact factor: 1.756

10.  Nutritional intake during continuous ambulatory peritoneal dialysis.

Authors:  A E Grzegorzewska; A Dobrowolska-Zachwieja; A Chmurak
Journal:  Adv Perit Dial       Date:  1997
View more
  8 in total

Review 1.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

2.  Beneficial effects of combination therapy of intradialytic parenteral nutrition and oral L-carnitine administration.

Authors:  Masataka Tsunoda; Ryota Ikee; Naomi Sasaki; Nobuo Hashimoto
Journal:  Int Urol Nephrol       Date:  2012-09-11       Impact factor: 2.370

3.  L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.

Authors:  Lorenzo Di Liberato; Arduino Arduini; Claudia Rossi; Augusto Di Castelnuovo; Cosima Posari; Paolo Sacchetta; Andrea Urbani; Mario Bonomini
Journal:  J Nephrol       Date:  2014-03-06       Impact factor: 3.902

4.  Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients.

Authors:  Celalettin Koşan; Lale Sever; Nil Arisoy; Salim Calişkan; Ozgür Kasapçopur
Journal:  Pediatr Nephrol       Date:  2003-10-02       Impact factor: 3.714

5.  Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis.

Authors:  Satoshi Shimizu; Hiroyuki Takashima; Ritsukou Tei; Tetsuya Furukawa; Makiyo Okamura; Maki Kitai; Chinami Nagura; Takashi Maruyama; Terumi Higuchi; Masanori Abe
Journal:  Nutrients       Date:  2019-11-04       Impact factor: 5.717

6.  Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study.

Authors:  Shohei Kaneko; Keiji Hirai; Junki Morino; Saori Minato; Katsunori Yanai; Yuko Mutsuyoshi; Hiroki Ishii; Momoko Matsuyama; Taisuke Kitano; Mitsutoshi Shindo; Akinori Aomatsu; Haruhisa Miyazawa; Yuichiro Ueda; Kiyonori Ito; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 7.  Significance of Levocarnitine Treatment in Dialysis Patients.

Authors:  Hiroyuki Takashima; Takashi Maruyama; Masanori Abe
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

Review 8.  Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis.

Authors:  Mario Bonomini; Lorenzo Di Liberato; Victor Zammit; Arduino Arduini
Journal:  Molecules       Date:  2019-09-23       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.